Older cancer patients and COVID-19 outbreak: Practical considerations and recommendations.


Journal

Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310

Informations de publication

Date de publication:
12 2020
Historique:
received: 12 05 2020
revised: 13 09 2020
accepted: 15 09 2020
pubmed: 22 11 2020
medline: 26 1 2021
entrez: 21 11 2020
Statut: ppublish

Résumé

Since the COVID-19 outbreak started, it has been affecting mainly older individuals. Among the most vulnerable older individuals are those with cancer. Many published guidelines and consensus papers deal with prioritizing cancer care. Given the lack of high-quality evidence for management of cancer in older patients also in normal times, it is even more stringent to provide some resources on how to avoid both undertreatment and overtreatment in this population, who as of now is twice challenged to death, due to both a greater risk of getting infected with COVID-19 as well as from cancer not adequately addressed and treated. We hereby discuss some general recommendations (implement triage procedures; perform geriatric assessment; carefully assess comorbidity; promote early integration of palliative care in oncology; acknowledge the role of caregivers; maintain active take in charge to avoid feeling of abandonment; mandate seasonal flu vaccination) and discuss practical suggestions for specific disease settings (early-stage and advanced-stage disease for solid tumors, and hematological malignancies). The manuscript provides resources on how to avoid both undertreatment and overtreatment in older patients with cancer, who as of now is twice challenged to death, due to both a greater risk of getting infected with COVID-19 as well as from cancer not adequately addressed and treated.

Identifiants

pubmed: 33219746
doi: 10.1002/cam4.3517
pmc: PMC7774711
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9193-9204

Informations de copyright

© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Références

Telemed J E Health. 2020 May;26(5):571-573
pubmed: 32275485
J Clin Oncol. 2012 May 10;30(14):1715-24
pubmed: 22493340
J Clin Oncol. 2017 Mar 10;35(8):834-841
pubmed: 28029308
PLoS One. 2019 Aug 30;14(8):e0221848
pubmed: 31469865
J Clin Oncol. 2009 Jan 1;27(1):16-23
pubmed: 19018080
J Clin Oncol. 2017 Sep 1;35(25):2871-2874
pubmed: 28628364
Oncologist. 2017 Dec;22(12):1528-1534
pubmed: 28894017
Eur J Cancer. 2015 Nov;51(16):2345-67
pubmed: 26254809
J Cancer Res Clin Oncol. 2016 May;142(5):1069-77
pubmed: 26758276
J Geriatr Oncol. 2020 Mar;11(2):311-315
pubmed: 31326393
JNCI Cancer Spectr. 2018 Nov 29;2(4):pky053
pubmed: 31360873
Appl Clin Inform. 2016 Apr 20;7(2):238-47
pubmed: 27437037
JAMA. 2017 Jan 3;317(1):48-58
pubmed: 28030702
Breast Cancer Res Treat. 2016 Apr;156(2):227-36
pubmed: 26988358
Eur J Cancer. 2020 May;130:155-167
pubmed: 32220780
J Gen Intern Med. 2018 Oct;33(10):1768-1773
pubmed: 30112737
Leuk Lymphoma. 2015 Apr;56(4):921-6
pubmed: 25110825
J Pain Symptom Manage. 2020 Jul;60(1):e5-e7
pubmed: 32240755
PLoS One. 2019 Aug 20;14(8):e0220988
pubmed: 31430345
Ann Surg Oncol. 2020 Jun;27(6):1713-1716
pubmed: 32285279
Eur J Surg Oncol. 2020 Mar;46(3):363-368
pubmed: 31973924
J Clin Oncol. 2006 Jan 20;24(3):394-400
pubmed: 16421419
Radiat Oncol. 2017 Mar 23;12(1):60
pubmed: 28335784
Ann Hematol. 2019 Mar;98(3):669-678
pubmed: 30443764
J Am Geriatr Soc. 2020 May;68(5):926-929
pubmed: 32255507
Br J Cancer. 2019 Oct;121(8):629-630
pubmed: 31527686
Cancer Med. 2020 Dec;9(24):9193-9204
pubmed: 33219746
Int J Cancer. 2020 Jan 15;146(2):321-328
pubmed: 30839100
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
J Geriatr Oncol. 2020 Nov;11(8):1349-1351
pubmed: 32482554
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):631-640
pubmed: 32589990
Clin Res Cardiol. 2020 May;109(5):531-538
pubmed: 32161990
Rejuvenation Res. 2008 Feb;11(1):151-61
pubmed: 18173367
Diabetes Metab Syndr. 2020 May - Jun;14(3):211-212
pubmed: 32172175
J Clin Oncol. 2009 Dec 1;27(34):5727-33
pubmed: 19786657
Lancet Oncol. 2020 May;21(5):619-621
pubmed: 32220659
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
Radiother Oncol. 2020 Jul;148:213-215
pubmed: 32342861
N Engl J Med. 2012 Feb 2;366(5):399-408
pubmed: 22149921
J Clin Oncol. 2006 May 20;24(15):2304-10
pubmed: 16710028
Eur J Cancer. 2016 Dec;69:199-215
pubmed: 27855351
J Oncol Pract. 2019 Apr;15(4):177-184
pubmed: 30970229
N Engl J Med. 2017 Oct 19;377(16):1585-1592
pubmed: 29045204
Nat Rev Clin Oncol. 2020 May;17(5):268-270
pubmed: 32242095
J Clin Oncol. 2014 Aug 20;32(24):2635-46
pubmed: 25071113
J Clin Oncol. 2018 Mar 1;36(7):710-719
pubmed: 29106810
Blood. 2018 Feb 1;131(5):515-524
pubmed: 29141942
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):618-627
pubmed: 32302681
Cancer. 2012 Jul 1;118(13):3377-86
pubmed: 22072065
J Clin Oncol. 2018 Oct 10;36(29):2943-2949
pubmed: 30106637
J Geriatr Oncol. 2020 Jun;11(5):761-763
pubmed: 32327321
J Geriatr Oncol. 2020 Jun;11(5):750-752
pubmed: 32278700
J Clin Oncol. 2012 May 20;30(15):1813-21
pubmed: 22529258
J Clin Oncol. 2018 Aug 1;36(22):2326-2347
pubmed: 29782209
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Lancet Oncol. 2019 Mar;20(3):352-360
pubmed: 30711522
Telemed J E Health. 2019 Feb;25(2):132-136
pubmed: 29847224
Lancet Oncol. 2020 Jul;21(7):914-922
pubmed: 32539942
Eur Urol. 2020 Mar;77(3):320-330
pubmed: 31771797
Cancers (Basel). 2020 Jul 08;12(7):
pubmed: 32650523
Br J Cancer. 2011 Apr 26;104(9):1393-400
pubmed: 21448163
Cancer. 2016 Feb 1;122(3):411-9
pubmed: 26540173
Oncologist. 2018 Apr;23(4):433-439
pubmed: 29242282
J Clin Oncol. 2019 Sep 10;37(26):2338-2348
pubmed: 31339827
Ann Oncol. 2012 Sep;23(9):2296-2300
pubmed: 22357257
BMC Psychiatry. 2020 Apr 6;20(1):154
pubmed: 32252700
Radiat Oncol. 2020 Jun 3;15(1):140
pubmed: 32493443
J Clin Oncol. 2011 Sep 1;29(25):3457-65
pubmed: 21810685
Am J Phys Med Rehabil. 2020 Jun;99(6):459-463
pubmed: 32324618
J Palliat Med. 2020 Dec;23(12):1653-1657
pubmed: 32216649
Acta Oncol. 2015 Nov;54(10):1737-46
pubmed: 25984931
Ann Surg. 2020 Aug;272(2):e81-e83
pubmed: 32675505

Auteurs

Antonella Brunello (A)

Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.

Antonella Galiano (A)

Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.

Silvia Finotto (S)

Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.

Silvio Monfardini (S)

Istituto Palazzolo Fondazione Don Gnocchi, Milano, Italy.

Giuseppe Colloca (G)

Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Istituto di Radiologia, Fondazione Policlinico A. Gemelli IRCCS - Università Cattolica Sacro Cuore, Roma, Italy.

Lodovico Balducci (L)

Moffitt Cancer Center, University of South Florida College of Medicine, Tampa, Florida, USA.

Vittorina Zagonel (V)

Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH